CPT 92941: Percutaneous Revascularization for Acute Myocardial Infarction
Medicare pays $590 and commercial payers pay $8144 on average nationally for this procedure.
CPT code 92941 describes a percutaneous transluminal revascularization procedure for acute myocardial infarction in which a catheter is inserted percutaneously into a coronary artery or coronary artery bypass graft to restore blood flow in a completely or nearly occluded vessel; the procedure may include angioplasty, stent placement, atherectomy, and/or manual aspiration thrombectomy, and is performed as a single-vessel intervention. Service type: emergent percutaneous coronary intervention (PCI). Typical site of service: hospital catheterization laboratory or interventional suite for treatment of an acute ST-elevation myocardial infarction.
For related coverage guidance, see recent payer policy updates: Cardiac Computed Tomography (CCT)/Coronary Computed Tomographic Angiography (CCTA), Cardiovascular Disease Risk Assessment, Biomarkers for Myocardial Infarction and Chronic Heart Failure.
Customize your policy alerts
Sign up for cpt 92941 policy alerts
Get alerted when payer policies referencing 92941 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Medicare's mean rate of $590.40 sits well below the BUCA average commercial mean of $8,143.60, illustrating a substantial gap between government and commercial benchmarks for CPT 92941. BUCA’s mean aligns with higher commercial medians such as Blue Cross Blue Shield and UnitedHealth Group, indicating that average commercial reimbursement levels can be an order of magnitude above Medicare for this code.
Examining dispersion (P75 minus P25) highlights where commercial markets are tight or wide: Blue Cross Blue Shield has the widest interquartile spread at $4,936.80 (P75 $16,196.40 minus P25 $11,259.60), followed by BUCA with $3,093.30 (P75 $9,826.50 minus P25 $6,733.20). Aetna and Cigna show narrower spreads of $577.00 and $666.00 respectively, while UnitedHealth Group’s spread is $650.00, indicating relatively tighter clustering among those payers compared with BCBS and BUCA.